Kallinikou Z, Arroyo D, Togni M, Lehmann S, Corpataux N, Cook M, Müller O, Baeriswyl G, Stauffer JC, Goy JJ, Puricel S, Cook S. Vascular response to DES vs BVS: OCT substudy of EVERBIO II. Swiss Medical Weekly. 2016.
Articles originaux
Puricel S, Kallinikou Z, Espinola J, Arroyo D, Goy JJ, Stauffer JC, Baeriswyl G, Smits PC, Cook S, Togni M. COMPARE-IT: vasomotor response after biodegradable polymer biolimus-eluting vs persistent polymer everolimus-eluting stents. International Journal of Cardiology. 2016;202:525–531.
Articles originaux
Puricel S, Arroyo D, Corpataux N, Baeriswyl G, Lehmann S, Kallinikou Z, Muller O, Stauffer JC, Togni M, Goy JJ, Cook S. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffold: a randomized controlled trial. Journal of the American College of Cardiology. 2015;65(8):794–803.
Articles originaux
Giraud R, Siegenthaler N, Arroyo D, Bendjelid K. Impact of epinephrine and norepinephrine on two dynamic indices in a porcine hemorrhagic shock. Journal of Trauma and Acute Care Surgery. 2014;77(4):564–569.
Articles originaux
Puricel S*, Arroyo D*, Goy JJ, Praz F, Wahl A, Stauffer JC, Togni M, Berger A, Meier B, Cook S. Swiss percutaneous patent foramen ovale closure in recurrent clinical events prevention – the SOLUTION registry. EuroIntervention. 2014. doi:10.4244/EIJY14M05_05.
Articles originaux
Palhais N*, Arroyo D*, Lehmann S, Togni M, Kaufmann U, Stauffer JC, Goy JJ, Cook S. Ten-year clinical follow-up after sirolimus-eluting stent implantation. American Heart Journal. 2014;167:893–899.
Articles originaux
Arroyo D, Togni M, Puricel S, Baeriswyl G, Lehmann S, Goy JJ, Stauffer JC, Cook S. Comparison of everolimus- and biolimus-eluting stents with everolimus-eluting bioresorbable vascular scaffold stents: study protocol of the randomized controlled EVERBIO II. Trials. 2014;15:9.
Articles originaux
Puricel S, Oberhänsli M, Guntern P, Lehmann S, Goy JJ, Arroyo D, Villeneuve H, Baeriswyl G, Stauffer JC, Togni M, Cook S. Long-term comparison of everolimus-eluting and biolimus-eluting stents in all-comer patients. EuroIntervention. 2013;8:0–0.
Chapitres de livres
Arroyo D, Puricel S, Togni M, Cook S. Effets aigus et chroniques des interventions coronariennes percutanées. In: Manuel de Cardiologie Interventionnelle. Éditions Frison-Roche.
Chapitres de livres
Cook S, Arroyo D, Puricel S, Togni M. Abnormal vasomotion after drug-eluting stent implantation. In: Coronary Stenosis Imaging, Structure and Physiology. 2nd ed.
Chapitres de livres
Arroyo D, Puricel S, Togni M, Cook S. Acute and chronic effects of percutaneous coronary interventions. In: Physiological Assessment of Coronary Stenoses and the Microcirculation. Springer; 2016.
Chapitres de livres
Puricel S, Arroyo D, Stadelmann M. Percutaneous coronary intervention with biodegradable scaffolds. In: Coronary Graft Failure – State of the Art. Springer; 2016:653–657.
